Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY was delisted on the 10th of August, 2023.
87 hedge funds and large institutions have $275M invested in Chinook Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 23 reducing their positions, and 19 closing their positions.
100% more call options, than puts
Call options by funds: $797K | Put options by funds: $398K
43% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 23
5% less funds holding
Funds holding: 92 → 87 (-5)
8% less capital invested
Capital invested by funds: $297M → $275M (-$22.3M)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$28.5M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$2.96M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.96M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.88M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$27.3M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$10.5M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.74M |
| 4 |
ORI
Oak Ridge Investments
Chicago,
Illinois
|
-$1.7M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$1.39M |
KDNY Hedge Fund Activity: Q4 2016 in Review
87 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q4 2016, worth a combined $275M — down 7.5% from $297M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of KDNY and 14 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 33 added.
The largest buyer was Wellington Management Group, adding an estimated $28.5M. The largest seller was Fidelity Investments, cutting an estimated $27.3M.
- 87 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q4 2016, down from 92 in Q3 2016.
- Funds reported $275M of Chinook Therapeutics, Inc. Common Stock stock for Q4 2016, down 7.5% quarter-over-quarter.
- 14 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q4 2016 and 19 closed out, a net change of -5 holders.
- The largest Chinook Therapeutics, Inc. Common Stock buyer in Q4 2016 was Wellington Management Group, an estimated $28.5M added.
- The largest Chinook Therapeutics, Inc. Common Stock seller in Q4 2016 was Fidelity Investments, an estimated $27.3M sold.
Based on aggregated 13F filings for Q4 2016.